{
    "clinical_study": {
        "@rank": "46724", 
        "arm_group": [
            {
                "arm_group_label": "Regenecure AMCA GBR Dental membrane", 
                "arm_group_type": "Experimental", 
                "description": "16 patients will undergo the guided bone regeneration procedure using the Regenecure AMCA Membrane"
            }, 
            {
                "arm_group_label": "Collagen membrane", 
                "arm_group_type": "Active Comparator", 
                "description": "16 patients will undergo the guided bone regeneration procedure using a commercially available collagen membrane"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine the safety and usefulness of the Regenecure guided\n      bone regeneration membrane for stimulating bone growth in patients that don't have enough\n      bone for dental implant placement. The study will include 16 patients in each group, 20\n      non-smokers and 12 smokers, a total of 32 patients will participate in the study."
        }, 
        "brief_title": "Guided Bone Regeneration Using Synthetic Membrane", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Jaw, Edentulous", 
            "Jaw, Edentulous, Partially"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Jaw, Edentulous", 
                "Jaw, Edentulous, Partially", 
                "Mouth, Edentulous"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject must have voluntarily signed the informed consent form before any study\n             related action\n\n          -  Age: 18 to 65 with missing teeth, seeking for implant therapy.\n\n          -  Men/Women\n\n          -  In good systemic health\n\n          -  Present with no contra indication against oral surgical interventions\n\n          -  Single/ multiple tooth gap - have at least one missing tooth in the mandible or\n             maxilla, requiring one or more dental implants.\n\n          -  The tooth at the implant site(s) must have been extracted or lost at least 6 weeks\n             before the date of implantation.\n\n          -  Bone defect(s) must be present with a lateral dimension greater than or equal to 5 mm\n             or less.\n\n          -  Full mouth plaque score (FMPI) lower or equal than 25%\n\n          -  Patients must be committed to the study\n\n        Exclusion Criteria:\n\n          -  Medical conditions requiring prolonged use of steroids\n\n          -  Use of Bisphosphonate intravenously\n\n          -  Current pregnancy or breastfeeding women\n\n          -  Alcoholism or chronically drug abuse\n\n          -  Immunocompromised patients\n\n          -  Uncontrolled Diabetes\n\n          -  Conditions or circumstances, in the opinion of the investigator, which would prevent\n             completion of study participation or interfere with analysis of study results, such\n             as history of non-compliance, or unreliability.\n\n          -  Untreated inflammation\n\n          -  Mucosal diseases or oral lesions\n\n          -  History of local irradiation therapy\n\n          -  Persistent intraoral infection\n\n          -  Patients with bad oral hygiene or unmotivated for normal home care."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01654627", 
            "org_study_id": "RGD001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Regenecure AMCA GBR Dental membrane", 
                "description": "Patients will undergo Guided Bone Regeneration (GBR) procedure using the Regenecure AMCA GBR Membrane", 
                "intervention_name": "Regenecure AMCA GBR Dental Membrane", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Collagen membrane", 
                "description": "The Geistlich Bio-Gide\u00ae collagen membrane, a commercially available product, will be used in 10 patients.", 
                "intervention_name": "Geistlich Bio-Gide\u00ae collagen membrane", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tranexamic Acid"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Guided Tissue Regeneration", 
            "Dental Implants", 
            "Membrane, Synthetic"
        ], 
        "lastchanged_date": "August 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel"
                }, 
                "name": "Department of Periodontology Hadassah and Hebrew University Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Horizontal Guided Bone Regeneration for Dental Implants Using Synthetic Membrane (Regenecures' AMCA GBR Dental Membrane) a Prospective, Randomized,Controlled Study.", 
        "overall_contact": {
            "email": "michal@regenecure.co.il", 
            "last_name": "Michal Limor, MD", 
            "phone": "+ 972-2-5401013"
        }, 
        "overall_official": {
            "affiliation": "Haddasah Medical Center, Jerusalem Israel", 
            "last_name": "Lior Shapira, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical effect on bone volume measured using CBCT. The volume of the newly formed bone will be evaluated by \"subtraction\" of the 2 cone beam CTs using digital measurements.", 
            "measure": "Bone volume", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in bone volume  at 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01654627"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Specimens will be prepared for histological staining (H&E and Masson's trichrome stain). The stained samples will be evaluated for new bone, residual bone graft,  marrow spaces and vascularity.", 
                "measure": "Histomorphometry", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Safety will be demonstrated by using VAS scale for pain measurements and if the PI will consider that any adverse event device related isn't clinically significant", 
                "measure": "Safety will be demonstrated by using VAS scale for pain measurements and if the PI will consider that any adverse event device related isn't clinically significant", 
                "safety_issue": "Yes", 
                "time_frame": "six months"
            }
        ], 
        "source": "RegeneCure, Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "RegeneCure, Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}